While methods for detecting SNVs and indels in circulating tumor DNA (ctDNA) with hybridization capture-based next-generation sequencing (NGS) have been available, copy number variations (CNVs) detection is more challenging. Here, we present a method enabling CNV detection from a 150-gene panel using a very low amount of ctDNA. First, a read depth-based CNV estimation method without a paired blood sample was developed and cfDNA sequencing data from healthy people were used to build a panel of normal (PoN) model. Then, in silico and in vitro simulations were performed to define the limit of detection (LOD) for EGFR, ERBB2, and MET. Compared to the WES results of the 48 samples, the concordance rate for EGFR, ERBB2, and MET CNVs was 78%, 89.6%, and 92.4%, respectively. In another cohort profiled with the 150-gene panel from 5980 lung cancer ctDNA samples, we detected the three genes’ amplification with comparable population frequency with other cohorts. One lung adenocarcinoma patient with MET amplification detected by our method reached partial response to crizotinib. These findings show that our ctDNA CNV detection pipeline can detect CNVs with high specificity and concordance, which enables CNV calling in a non-invasive way for cancer patients when tissues are not available.
1 December 2020 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Background: 5-fluorouracil (5-FU) is a common chemotherapy drug for gastric cancer. Human antigen R (HuR) is an RNA-binding protein that is also known as ELAV like RNA binding protein 1 (ELAVL1) regulates gene expression by binding to target genes 3' UTR region and is highly expressed in tumor tissues. However, the regulatory mechanisms of HuR in 5-FU mediated chemotherapy in stomach cancer are not well understood. In this study, we aimed to investigate 5-FU regulated PKCδ expression and translocation of HuR in SGC cell lines. Methods: Using Cell viability assay to obtained IC50 doses when SGC cells were treated with 5-FU for 2 and 3 days. Western blot was used to detect the total protein content of HuR and PKCδ after treating with 20 mM 5-FU. Furthermore, after adding 20 mM 5-FU, knocking down PKCδ, HuR and using inhibitor Staurosporine respectively, the protein content of HuR in the cytoplasm were detected by Western blot and Immunofluorescence. MTT assay was used to verify the changes in cell proliferation after knockdown of HuR. Results: Using Cell viability assay, we obtained IC50 doses of 77 and 20 mM, respectively, when SGC cells were treated with 5-FU for 2 and 3 days. The total protein content of HuR and PKCδ in SGC cells treated with 20 mM 5-FU did not change. However, Western blot and Immunofluorescence detected that the protein content of HuR in the cytoplasm decreased with 20 mM 5-FU treatment. Staurosporine inhibits the nucleation of HuR and is an inhibitor of PKC. Consistently, the expression of HuR in cytoplasm declined while knockdown of PKCδ. And the proliferation of SGC cells decreased after knocking down the HuR. Conclusions: Our results showed that 5-FU blocked shuttling of HuR from the nucleus to the cytoplasm in SGC cells through PKCδ phosphorylation.
Gene expression data from microarrays have been successfully applied to class prediction, where the purpose is to classify and predict the diagnostic category of a sample by its gene expression profile. A typical microarray dataset consists of expression levels for a large number of genes on a relatively small number of samples. As a consequence, one basic and important question associated with class prediction is: how do we identify a small subset of informative genes contributing the most to the classification task? Many methods have been proposed but most focus on two-class problems, such as discrimination between normal and disease samples. This paper addresses selecting informative genes for multiclass prediction problems by jointly considering all the classes simultaneously. Our approach is based on the power of the genes in discriminating among the different classes (e.g., tumor types) and the existing correlation between genes. We formulate the expression levels of a given gene by a one-way analysis of variance model with heterogeneity of variances, and determine the discriminatory power of the gene by a test statistic designed to test the equality of the class means. In other words, the discriminatory power of a gene is associated with a Behrens-Fisher problem. Informative genes are chosen such that each selected gene has a high discriminatory power and the correlation between any pair of selected genes is low. Test statistics considered in this paper include the ANOVA F test statistic, the Brown-Forsythe test statistic, the Cochran test statistic, and the Welch test statistic. Their performances are evaluated over several classification methods applied to two publicly available microarray datasets. The results show that Brown-Forsythe test statistic achieves the best performance.